About Evdokia Anagnostou
Born 1971. Evdokia Anagnostou is a Canadian pediatrician and neurologist.
Evdokia Anagnostou is a Canadian pediatric neurologist. She is a professor in the Department of Pediatrics at the University of Toronto, and is cross-appointed as pediatric neurologist and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. She is a Tier 2 Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder.
Career Anagnostou is currently a professor in the Department of Pediatrics at the University of Toronto, and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. Her research focuses on translating findings from basic research studies in the field of Autism Spectrum Disorder and related neurodevelopmental conditions into novel therapeutics. Upon realizing that patients with Autism Spectrum Disorder often have additional disorders (including intellectual disability, ADHD and OCD), Anagnostou and her colleagues launched the Province of Ontario Neurodevelopmental Disorders (POND) Network in 2013 to study multiple neurodevelopmental disorders (including Autism Spectrum Disorder) together. She is a principal investigator at POND, funded by the Ontario Brain Institute. POND co-investigators include Stephen W. Scherer. She was also appointed as a Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder in November 2017. She is an associate editor for Molecular Autism and Autism Research, and a grant reviewer for multiple international agencies
Anagnostou's research has been cited over 23,000 times and has an h-index of 71. She regularly comments on Autism Spectrum Disorder as an expert on various Canadian media platforms.
Selected bibliography Hollander et al. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biological Psychiatry. 2005. Hollander et al. Oxytocin increases retention of social cognition in autism. Biological Psychiatry. 2007. King et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry. 2009. Glessner et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009. Pinto et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. The American Journal of Human Genetics. 2014.
Honours and awards Inaugural Dr. Stuart D. Sims Chair in Autism at the Holland Bloorview Kids Rehabilitation Hospital Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder
Don’t just read it —
keep it.
Full-length biographies made to live with: read them, listen on the way to work, watch them tonight.
- E-book
- Audio
- Video
Instant download · yours to keep · every purchase keeps this site free
Important facts
Contemporaries
People whose lives overlapped Evdokia Anagnostou's
Frequently asked questions
Who is Evdokia Anagnostou?
Canadian pediatric neurologist
When was Evdokia Anagnostou born?
Evdokia Anagnostou was born on 24 June 1971.
What is Evdokia Anagnostou's occupation?
Evdokia Anagnostou is a pediatrician and neurologist.
What nationality is Evdokia Anagnostou?
Evdokia Anagnostou is Canadian.
Sources & further reading
· Wikipedia: Evdokia Anagnostou
· DBpedia: Evdokia Anagnostou
Cite this page
APA: Biography.guide. (2026). Evdokia Anagnostou. https://biography.guide/evdokia-anagnostou/
MLA: "Evdokia Anagnostou." Biography.guide, https://biography.guide/evdokia-anagnostou/.
Chicago: "Evdokia Anagnostou." Biography.guide. https://biography.guide/evdokia-anagnostou/.
Data last updated: 2026-09-20 · Spot an error? Report a correction.
Page generated 2026-09-27 05:16 UTC